Global Epidemiology Network for Enhancing Systems and Innovation in Regulatory Science

The GENESIS project (Global Epidemiology Network for Enhancing Systems and Innovation in Regulatory Science) is a collaborative initiative centred between UCL and Sungkyunkwan University (SKKU) in South Korea, with contributions from a global network of partners. Funded by the Korea Ministry of Food and Drug Safety, this project addresses critical global challenges in drug safety and efficacy by leveraging real-world data (RWD) from diverse populations across Asia, Europe, and North America. GENESIS aims to generate high-quality evidence to inform regulatory decisions and improve health outcomes on a global scale.

This PhD studentship at UCL is a core component of the GENESIS project, dedicated to advancing research in mental health and maternal-child health domains. The successful candidate will work on multinational studies, utilising large-scale international datasets to tackle key questions about medication safety and effectiveness. By connecting expertise from UCL, SKKU, and collaborators worldwide, the GENESIS project fosters innovation in regulatory science and builds the next generation of leaders in pharmacoepidemiology and real-world data research.

The supervisor for this studentship is Dr Kenneth Man.

Main methods and techniques

This project will leverage cutting-edge techniques in pharmacoepidemiology and advanced statistical methods to analyse extensive datasets from multiple countries. Researchers will employ robust methodologies such as statistical modelling and data harmonisation tailored for real-world evidence studies. These approaches are critical for addressing intricate questions about drug safety and effectiveness across diverse populations while maintaining scientific rigour and accuracy.

The PhD candidate in this project will gain a comprehensive skillset, including proficiency in managing and analysing large-scale real-world data, a deep understanding of international regulatory frameworks, and experience in interdisciplinary collaboration. The research will utilise harmonised multinational data to investigate the influence of cultural and healthcare system differences on various health outcomes, ensuring the findings are both meaningful and generalisable. By integrating expertise in pharmacy, regulatory science, and data analysis, this work will produce evidence that meets the needs of healthcare providers, patients, and policymakers globally.

Person specification

Applicants are expected to hold a first degree in Pharmacy, Epidemiology, Statistics, or Computer Science (minimum 2.1). Other relevant skills will be taught during the project.

Applicants will also need to meet UCL MPhil/PhD entry and English Language requirements. See here for further details.

This studentship is open to Home UK applicants only. The student stipend will be paid at UCL normal rates (the stipend rate for 2024/25 is £21,237).

How to apply

Applications must include CV, personal statement, and the contact details of two referees. Applications should be emailed to Ms Michelle Ward at [email protected].

The deadline for applications is 31^st January 2025 and interviews will take place on thereafter. It is hoped that the project will commence in May 2025.